A recent publication in Gatroenterolgy has led to some great press for the Precision-Panc platform.
The team used cells grown in the lab and organoids to identify molecular markers that can predict which tumours will respond to a number of drugs that target damaged DNA.
This strategy is now being taken forward into the PRIMUS 004 trial – more information about this will be added to the website very soon so keep an eye out.
If you would like to know more about the recent publication please have a look at the links below.
https://medicalxpress.com/news/2020-10-scientists-precision-medicine-approach-dna.html